Treatment of Hodgkin's disease: The role of radio- and/or chemotherapy in advanced stages

Bailliere's Clinical Haematology

Volumn 9, Issue 3, 1996, Pages 553-558

  Straus, D J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; CHLORMETHINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; CANCER STAGING; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DRUG MIXTURE; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT PLANNING;

EID: 0029809237     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(96)80026-6     Document Type: Article

References (26)

1. Bartlett NL Rosenberg SA Hoppe RA Brief chemotherapy Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: A preliminary report Journal of Clinical Oncology 13 1995 1080 1088
2. Bonadonna G Valagussa P Santoro A Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease: A report of 8-year results Annals of Internal Medicine 104 1986 739 746
3. Bonfante V Santoro A Viviani S ABVD in the treatment of Hodgkin's disease Seminars in Oncology 19 1992 38 45 supplement 5
4. Brizel DM Winer EP Prosnitz LR Improved survival with the use of combined modality therapy International Journal of Radiation Oncology Biology Physics 19 1990 535 542
5. Canellos GP Anderson JR Propert KJ Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD New England Journal of Medicine 327 1992 1478 1484
6. (abstract) Connors JM Klimo P Adams G MOPP/ABV hybrid versus alternating MOPP/ABVD for advanced Hodgkin's disease Proceedings of the American Society of Clinical Oncology 11 1992 317
7. Cullen MH Stuart NSA Woodroffe C ChlVPP/ABIOE and radiotherapy in advanced Hodgkin's disease Journal of Clinical Oncology 12 1994 779 787
8. Fabian CJ Mansfield CM Dahlberg S Low-dose involved field radiation after chemotherapy in advanced Hodgkin's disease. A Southwest Oncology Group randomized study Annals of Internal Medicine 120 1994 903 912
9. (abstract) Glick J Tsiatis A Schilsky R A randomized phase II trial of MOPP/ABV hybrid vs. sequential MOPP-ABVD in advanced Hodgkin's disease: preliminary results of the Intergroup trial. ECOG, CALGB, and SWOG Proceedings of the American Society of Clinical Oncology 10 1991 271
10. Gobbi PG Pieresca C Federico M MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group Journal of Clinical Oncology 11 1993 712 719
11. Hancock BW Vaughn Hudson G Vaughn Hudson B LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: the results of a British National Lymphoma Investigation Trial Journal of Clinical Oncology 10 1992 1252 1258
12. Hancock BW Vaughn Hudson G Vaughn Hudson B British National Lymphoma Investigation randomized study of MOPP (mustine, oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. Long term results British Journal of Cancer 63 1991 579 582
13. Horning SJ Ang PT Hoppe RT Rosenberg SA The Stanford experience with combined procarbazine, Alkeran and vinblastine (PAVe) and radiotherapy for locally extensive and advanced stage Hodgkin's disease Annals of Oncology 3 1992 747 754
14. Klimo P Connors JM An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV hybrid program Seminars in Hematology 25 1988 34 40 supplement 2
15. Loeffler M Pfreundschuh M Hasenclever D Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study Group Blut 56 1988 273 281
16. Longo DL Young RC Wesley M Twenty years of MOPP therapy for Hodgkin's disease Journal of Clinical Oncology 4 1986 1295 1306
17. Longo DL Russo A Duffy PL Treatment of advance-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment Journal of Clinical Oncology 9 1991 227 235
18. Longo DL Duffy PL DeVita VT Treatment of advanced-stage Hodgkin's disease: alternating non-cross-resistant MOPP/CABS is not superior to MOPP Journal of Clinical Oncology 9 1991 1409 1420
19. Pavlovsky S Santarelli MJ Sackmann Muriel F Randomized trial chemotherapy versus chemotherapy plus radiotherapy for stage III–IVA Hodgkin's disease Annals of Oncology 7 1992 533 537
20. Ranson MR Radford JA Swindell R An analysis of prognostic factors in stage III and IV Hodgkin's disease at a single centre with MVPP Annals of Oncology 2 1991 423 429
21. Santoro A Bonadonna G Valagussa P Long-term results of combined chemotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy Journal of Clinical Oncology 5 1987 27 37
22. Selby P Patel P Milan S CHIVPP combination chemotherapy for Hodgkin's disease: long term results British Journal of Cancer 62 1990 279 285
23. Somers R Carde P Henry-Amar M A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alternation of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial Journal of Clinical Oncology 12 1994 279 287
24. Straus DJ Gaynor JJ Myers J Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially non-cross-resistant chemotherapy and intermediate-dose radiation therapy Journal of Clinical Oncology 8 1990 1173 1186
25. Viviani S Bonadonna G Santoro A Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience Annals of Oncology 2 supplement 2 1991 55 62
26. Yahalom J Ryu J Straus DJ Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations Journal of Clinical Oncology 9 1991 2193 2201